天然产物研究与开发 ›› 2018, Vol. 30 ›› Issue (增刊2): 173-178.

• 开发研究 • 上一篇    下一篇

基于老药新用的气滞胃痛颗粒治疗慢性反流性胃炎作用机制研究

韩凌1,辛明媛2,包永睿3,4,5,王帅3,4,5,李天娇3,4,5,杨欣欣3,4,5,孟宪生3,4,5*   

  1. 1辽宁华润本溪三药有限公司,本溪 117004;2东北国际医院,沈阳 110623;3辽宁中医药大学药学院;4辽宁省组分中药工程技术研究中心;5辽宁省现代中药研究工程实验室,大连 116600
  • 出版日期:2019-01-18 发布日期:2019-01-18
  • 基金资助:

    辽宁省特聘教授项目(辽教发[2014]187号);辽宁省高等学校创新团队支持计划项目(辽教函[2018]39号)

Study on the Mechanism of Qizhiweitong Granules Treating Chronic Reflux Gastritis Based on the New Use of Old Medicine

HAN Ling1,XIN Ming-yuan2,BAO Yong-rui3,4,5,WANG Shuai3,4,5,LI Tian-jiao3,4,5,YANG Xin-xin3,4,5,MENG Xian-sheng3,4,5*   

  1. 1China Resources in Liaoning Benxi Third Pharmaceutical Co.,Ltd.,Benxi Liaoning 117004,China; 2Northeast International Hospital,Shenyang 110623,China; 3School of Pharmacy,Liaoning University of Traditional Chinese Medicine; 4Province Multi-Component Chinese Medicine Engineering Technology Research Center of Liaoning; 5Modern Traditional Chinese Medicine Research and Engineering Laboratory of Liaoning,Dalian Liaoning 116600,China
  • Online:2019-01-18 Published:2019-01-18

摘要: 探讨气滞胃痛颗粒治疗慢性反流性胃炎的作用机制,为其临床新适应症的研究开发奠定基础。采用代谢组学的研究方法,对慢性反流性胃炎大鼠及气滞胃痛颗粒各给药组血清内源性物质进行分析,Agilent MPP 12.1软件对数据进行倍数检验、主成分分析,寻找各组中血清差异化合物,并对差异化合物进行结构鉴定与代谢通路分析。倍数检验结果显示,空白组与模型组在内源性化合物水平存在显著差异;主成分分析结果说明各组与模型组均得到较好分离;气滞胃痛颗粒治疗组血清中鉴定出22个差异化合物,涉及氨基酸代谢、鞘磷脂代谢、花生四烯酸代谢、嘌呤代谢等代谢通路。本研究从内源性化合物变化角度揭示气滞胃痛颗粒治疗慢性反流性胃炎的作用机制,为该方在治疗反流性胃炎方面的临床应用提供数据支持。

关键词: 气滞胃痛颗粒, 老药新用, 慢性反流性胃炎, 代谢组学, 作用机制

Abstract: In order to explore the mechanism of Qizhiweitong Granules treating chronic reflux gastritis,lay a foundation for the research and development of new indications.Using the method of metabonomics to study the serum endogenous substance of rats with chronic reflux gastritis and administrated with Qizhiweitong Granules.Agilent MPP 12.1 software was used to perform multiple tests and principal component analysis of the data,to find the serum difference compounds in each group,and to conduct structural identification and metabolic pathway analysis of the difference compounds.Multiple testing results showed that there were significant differences in endogenous compound levels between the blank group and the model group.Principal component analysis results showed that each group was well separated from the model group.There were 22 different compounds identified in the serum of the treatment group of Qizhiweitong Granules,refering amino acid metabolism,phospholipid metabolism,arachidonic acid metabolism,purine metabolism and other metabolic pathways.This study from the perspective of endogenous compounds changes to reveal the mechanism of Qizhiweitong Granules treating chronic reflux gastritis,which provide data support for the clinical application.

Key words: Qizhiweitong Granules, Older drugs new use, Chronic reflux gastritis, Metabonomics, Mechanism of action

中图分类号:  R285.5